Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Amgen
(NQ:
AMGN
)
313.69
+0.87 (+0.28%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Amgen
< Previous
1
2
...
18
19
20
21
22
23
24
25
26
...
42
43
Next >
NeurAxis: Should You Buy This IPO?
February 08, 2023
As NeurAxis is ready to launch its IPO, we take a closer look to see if investors should be buying into the hype.
Via
Talk Markets
Beat the Dow Jones With This Unstoppable Dividend Stock
February 08, 2023
This pharmaceutical company has outperformed the Dow Jones index over the last 10 years.
Via
The Motley Fool
Is Biotech Immunocore About To Make A 25% Price Move?
February 07, 2023
Small-cap Immunocore has been a price leader within the biotech industry. Analysts have a "buy" rating on the stock and estimate that it will move 25% higher.
Via
MarketBeat
Topics
ETFs
NeurAxis IPO Sets Stage To Take On Irritable Bowel Syndrome With A Non-Surgical Solution
February 06, 2023
As NeurAxis gears up for its upcoming IPO, we take a deep dive into the company to see if it's worth adding to your investment portfolio.
Via
Talk Markets
Will These 3 Potential Blockbuster Drugs Lift Bristol Myers Squibb?
February 04, 2023
Bristol Myers Squibb has solid replacements for its blockbusters that are facing a patent cliff.
Via
The Motley Fool
Why Amgen Stock Wilted on Wednesday
February 01, 2023
The company's latest quarter wasn't its most impressive.
Via
The Motley Fool
Amgen Sinks On Mixed Earnings As 2023 Guidance Comes Up Short
January 31, 2023
Amgen reported lighter-than-expected earnings, but sales beat forecasts.
Via
Investor's Business Daily
Here's How Much You Would Have Made Owning Amgen Stock In The Last 15 Years
January 30, 2023
Via
Benzinga
Market Rally Powers Higher On Tame Fed, Meta Earnings; Apple, Google, Amazon In Focus: Weekly Review
February 03, 2023
The major indexes continued to run despite mixed-to-weak earnings.
Via
Investor's Business Daily
Top 5 Health Care Stocks That May Rally
February 03, 2023
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Via
Benzinga
The 7 Most Undervalued Dow Stocks to Buy in February 2023
February 02, 2023
If you’re looking for the best deals among the most iconic enterprises, these are the most undervalued Dow stocks to buy.
Via
InvestorPlace
Earnings Preview: Amgen
January 30, 2023
Via
Benzinga
2 Top Passive-Income Stocks to Own in 2023
January 22, 2023
These dividend stocks can deliver both downside protection and capital appreciation.
Via
The Motley Fool
Analyst Expectations for Amgen's Future
January 19, 2023
Via
Benzinga
$100 Invested In Amgen 15 Years Ago Would Be Worth This Much Today
January 10, 2023
Via
Benzinga
Why Amgen Shares Are Falling
February 01, 2023
Amgen, Inc. (NASDAQ: AMGN) shares are trading lower by 3.85% to $242.69 Wednesday morning after the company reported fourth-quarter financial results and issued FY23 revenue guidance below estimates....
Via
Benzinga
Amgen Records Slight Fall In Quarterly Earnings; Lower COVID-19 Manufacturing Pacts Impact Bottomline
February 01, 2023
Via
Benzinga
AbbVie's Two-Decade Humira Monopoly Ends With Amgen's 55% Discounted Knockoff
January 31, 2023
Amgen launched its biosimilar knockoff on Tuesday at a steep discount.
Via
Investor's Business Daily
Nasdaq, S&P Futures Lower As Powell & Team Kick Off 2-Day Fed Meeting: Analyst Says Positive January Harbinger Of Good Times
January 31, 2023
Trading in the major U.S. index futures suggests stocks may extend their losses for a second straight session.
Via
Benzinga
Amgen Layoffs 2023: What to Know About the Latest AMGN Job Cuts
January 30, 2023
Wall street is buzzing over Amgen layoffs today. The biotech company announced it laid off 300 of its U.S. employees.
Via
InvestorPlace
Earnings Scheduled For January 31, 2023
January 31, 2023
Companies Reporting Before The Bell • Biophytis (NASDAQ:BPTS) is projected to report earnings for its first quarter.
Via
Benzinga
Can Market Sustain Upward Momentum In Tech-Heavy Earnings Week? Apple, Amazon, AMD, Alphabet, Ford Among Key Quarterly Reports To Watch
January 29, 2023
With a full week of earnings behind us, it’s time to take stock of the fourth-quarter reporting season so far. Overall, the news flow has been mixed, although tech earnings have grossly disappointed.
Via
Benzinga
2 Top Biotech Stocks to Buy for the Long Haul
January 26, 2023
Developing new products will be key to the success of both of these biotech leaders.
Via
The Motley Fool
Dogs of the Dow 2023: 5 Dividend Stocks for Income Investors
January 24, 2023
The 2023 Dogs of the Dow feature several stocks investors should consider for their income portfolios. Here are the top five picks.
Via
InvestorPlace
6 Dividend Growth Stocks
January 22, 2023
Interested in knowing about companies that are paying their shareholders even bigger dividends than before? Today I want to tell you about six dividend growth stocks that just increased their...
Via
Talk Markets
3 Dividend Stocks You Can Safely Hold for Years
January 21, 2023
Look for the top companies in businesses the world perpetually needs.
Via
The Motley Fool
Analyst Views Novo Nordisk's Upcoming Obesity Drug Data To Lay Grounds For Eli Lilly's Tirzepatide
January 19, 2023
Cantor Fitzgerald published around 40-page deep dive ahead of Novo Nordisk A/S's (NYSE: NVO) SELECT CV outcomes study, which is guided to complete in ~mid-2023.
Via
Benzinga
Building A Dividend Growth Portfolio To Meet Your Unique Needs
January 11, 2023
A look at how investors can utilize creative strategies that apply to their own financial situation to build portfolios that work for them.
Via
Talk Markets
Illumina Shares Tank After Annual Guidance Fall Short Of Expectations
January 10, 2023
Via
Benzinga
The Dogs of the Dow Worked Last Year, But This Strategy Could Make You More Money in 2023
January 08, 2023
Meet the Dogs of the S&P.
Via
The Motley Fool
< Previous
1
2
...
18
19
20
21
22
23
24
25
26
...
42
43
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.